XSWX:BSLN (Switzerland)  
Basilea Pharmaceutica Ltd logo

Basilea Pharmaceutica Ltd

CHF 38.15 (-1.42%) Sep 26
P/E:
165.87
P/B:
0
Market Cap:
CHF 451.70M ($ 455.78M)
Enterprise V:
CHF 542.27M ($ 547.18M)
Volume:
17.04K
Avg Vol (2M):
37.92K
Also Trade In:
Volume:
17.04K
Market Cap CHF:
451.70M
Market Cap $:
455.78M
PE Ratio:
165.87
Avg Vol (2-Month):
37.92K
Enterprise Value CHF:
542.27M
Enterprise Value $:
547.18M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Basilea Pharmaceutica Ltd is a biotechnology company that focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections, and oncology. The company aims to develop drugs in order to target the medical challenge of resistance and non-response to current treatment options. The company's research strategy integrates the areas of genomics, cell biology, medicinal chemistry, and pharmacology. Its commercial product comprises of Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections.
Name Current Vs Industry Vs History
Cash-To-Debt 0.61
Equity-to-Asset -0.29
Debt-to-Equity -3.44
Debt-to-EBITDA 24.57
Interest Coverage 1.24
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.95
Distress
Grey
Safe
Beneish M-Score 0.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.95
9-Day RSI 39.22
14-Day RSI 42.53
6-1 Month Momentum % 8.48
12-1 Month Momentum % -11.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.36
Quick Ratio 1.2
Cash Ratio 0.91
Days Inventory 327.16
Days Sales Outstanding 33.9
Days Payable 98.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.3

Financials

XSWX:BSLN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 152.571
EPS (TTM) (CHF) 0.23
Beta 1.21
Volatility % 37.09
14-Day RSI 42.53
14-Day ATR (CHF) 1.293503
20-Day SMA (CHF) 39.0525
12-1 Month Momentum % -11.68
52-Week Range (CHF) 29.55 - 47.14
Shares Outstanding (Mil) 11.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Basilea Pharmaceutica Ltd Filings

Document Form Filing Date
No Filing Data

Basilea Pharmaceutica Ltd Analysis

Share your research